Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review

Co‐morbidities in idiopathic pulmonary fibrosis are common. These co‐morbidities include obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression. The presence of co‐morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respirology (Carlton, Vic.) Vic.), 2016-08, Vol.21 (6), p.995-1004
Hauptverfasser: de Boer, Kaïssa, Lee, Joyce S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1004
container_issue 6
container_start_page 995
container_title Respirology (Carlton, Vic.)
container_volume 21
creator de Boer, Kaïssa
Lee, Joyce S.
description Co‐morbidities in idiopathic pulmonary fibrosis are common. These co‐morbidities include obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression. The presence of co‐morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality of life, morbidity and mortality. Despite the high prevalence of certain co‐morbidities in idiopathic pulmonary fibrosis, the optimal screening and management of many of these conditions remains unclear. The impact of co‐morbidities on this patient population is becoming more apparent. Their relevance will only increase as significant effort is being made to develop novel therapeutics that will alter the disease trajectory of patients with idiopathic pulmonary fibrosis. The purpose of this review is to focus on the epidemiology, pathophysiology, diagnosis and management of select co‐morbidities, including obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression, in idiopathic pulmonary fibrosis.
doi_str_mv 10.1111/resp.12622
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808640606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1804865593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5062-df633b282b4c4e4ed4e9c7fcbc2cde73cd449be16ab0a6f42e598a66784b53593</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EglLY8AEoS4QU8DsJuwoBBSpAPMTSip0JGPLCbin9e1xaukTMZmZx7pHmIrRH8BEJc-zAd0eESkrXUI9wjmOScrYebkZZnCRZtoW2vX_DGDOBxSbaopJJQQXpoaunpgAXOzDtS2M9FJFp47p12hZ2bMFHtonC2Xb5-NWaqJtUddvkbhaVVrvWW38SDSIHnxamO2ijzCsPu8vdR0_nZ4-nw3h0e3F5OhjFRmBJ46KUjGmaUs0NBw4Fh8wkpdGGmgISZgrOMw1E5hrnsuQURJbmUiYp14KJjPXRwcLbufZjAn6sausNVFXeQDvxiqQ4lRxLLP-D8lSKIA3o4QI14S3voFSds3X4VBGs5jWrec3qp-YA7y-9E11DsUJ_ew0AWQBTW8HsD5W6P3u4-5XGi4z1Y_haZXL3rmTCEqGeby7U8PGcY3GN1TX7BmpVlw0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1804865593</pqid></control><display><type>article</type><title>Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review</title><source>MEDLINE</source><source>Wiley Journals</source><creator>de Boer, Kaïssa ; Lee, Joyce S.</creator><creatorcontrib>de Boer, Kaïssa ; Lee, Joyce S.</creatorcontrib><description>Co‐morbidities in idiopathic pulmonary fibrosis are common. These co‐morbidities include obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression. The presence of co‐morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality of life, morbidity and mortality. Despite the high prevalence of certain co‐morbidities in idiopathic pulmonary fibrosis, the optimal screening and management of many of these conditions remains unclear. The impact of co‐morbidities on this patient population is becoming more apparent. Their relevance will only increase as significant effort is being made to develop novel therapeutics that will alter the disease trajectory of patients with idiopathic pulmonary fibrosis. The purpose of this review is to focus on the epidemiology, pathophysiology, diagnosis and management of select co‐morbidities, including obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression, in idiopathic pulmonary fibrosis.</description><identifier>ISSN: 1323-7799</identifier><identifier>EISSN: 1440-1843</identifier><identifier>DOI: 10.1111/resp.12622</identifier><identifier>PMID: 26365251</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Comorbidity ; depression ; Depression - epidemiology ; Disease Management ; gastro-oesophageal reflux disease ; Gastroesophageal Reflux - epidemiology ; Humans ; Hypertension, Pulmonary - epidemiology ; idiopathic pulmonary fibrosis ; Idiopathic Pulmonary Fibrosis - diagnosis ; Idiopathic Pulmonary Fibrosis - epidemiology ; Idiopathic Pulmonary Fibrosis - physiopathology ; Idiopathic Pulmonary Fibrosis - therapy ; obstructive sleep apnoea ; Prevalence ; pulmonary hypertension ; Sleep Apnea, Obstructive - epidemiology</subject><ispartof>Respirology (Carlton, Vic.), 2016-08, Vol.21 (6), p.995-1004</ispartof><rights>2015 Asian Pacific Society of Respirology</rights><rights>2015 Asian Pacific Society of Respirology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5062-df633b282b4c4e4ed4e9c7fcbc2cde73cd449be16ab0a6f42e598a66784b53593</citedby><cites>FETCH-LOGICAL-c5062-df633b282b4c4e4ed4e9c7fcbc2cde73cd449be16ab0a6f42e598a66784b53593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fresp.12622$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fresp.12622$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26365251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Boer, Kaïssa</creatorcontrib><creatorcontrib>Lee, Joyce S.</creatorcontrib><title>Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review</title><title>Respirology (Carlton, Vic.)</title><addtitle>Respirology</addtitle><description>Co‐morbidities in idiopathic pulmonary fibrosis are common. These co‐morbidities include obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression. The presence of co‐morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality of life, morbidity and mortality. Despite the high prevalence of certain co‐morbidities in idiopathic pulmonary fibrosis, the optimal screening and management of many of these conditions remains unclear. The impact of co‐morbidities on this patient population is becoming more apparent. Their relevance will only increase as significant effort is being made to develop novel therapeutics that will alter the disease trajectory of patients with idiopathic pulmonary fibrosis. The purpose of this review is to focus on the epidemiology, pathophysiology, diagnosis and management of select co‐morbidities, including obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression, in idiopathic pulmonary fibrosis.</description><subject>Comorbidity</subject><subject>depression</subject><subject>Depression - epidemiology</subject><subject>Disease Management</subject><subject>gastro-oesophageal reflux disease</subject><subject>Gastroesophageal Reflux - epidemiology</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - epidemiology</subject><subject>idiopathic pulmonary fibrosis</subject><subject>Idiopathic Pulmonary Fibrosis - diagnosis</subject><subject>Idiopathic Pulmonary Fibrosis - epidemiology</subject><subject>Idiopathic Pulmonary Fibrosis - physiopathology</subject><subject>Idiopathic Pulmonary Fibrosis - therapy</subject><subject>obstructive sleep apnoea</subject><subject>Prevalence</subject><subject>pulmonary hypertension</subject><subject>Sleep Apnea, Obstructive - epidemiology</subject><issn>1323-7799</issn><issn>1440-1843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtOwzAQRS0EglLY8AEoS4QU8DsJuwoBBSpAPMTSip0JGPLCbin9e1xaukTMZmZx7pHmIrRH8BEJc-zAd0eESkrXUI9wjmOScrYebkZZnCRZtoW2vX_DGDOBxSbaopJJQQXpoaunpgAXOzDtS2M9FJFp47p12hZ2bMFHtonC2Xb5-NWaqJtUddvkbhaVVrvWW38SDSIHnxamO2ijzCsPu8vdR0_nZ4-nw3h0e3F5OhjFRmBJ46KUjGmaUs0NBw4Fh8wkpdGGmgISZgrOMw1E5hrnsuQURJbmUiYp14KJjPXRwcLbufZjAn6sausNVFXeQDvxiqQ4lRxLLP-D8lSKIA3o4QI14S3voFSds3X4VBGs5jWrec3qp-YA7y-9E11DsUJ_ew0AWQBTW8HsD5W6P3u4-5XGi4z1Y_haZXL3rmTCEqGeby7U8PGcY3GN1TX7BmpVlw0</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>de Boer, Kaïssa</creator><creator>Lee, Joyce S.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201608</creationdate><title>Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review</title><author>de Boer, Kaïssa ; Lee, Joyce S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5062-df633b282b4c4e4ed4e9c7fcbc2cde73cd449be16ab0a6f42e598a66784b53593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Comorbidity</topic><topic>depression</topic><topic>Depression - epidemiology</topic><topic>Disease Management</topic><topic>gastro-oesophageal reflux disease</topic><topic>Gastroesophageal Reflux - epidemiology</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - epidemiology</topic><topic>idiopathic pulmonary fibrosis</topic><topic>Idiopathic Pulmonary Fibrosis - diagnosis</topic><topic>Idiopathic Pulmonary Fibrosis - epidemiology</topic><topic>Idiopathic Pulmonary Fibrosis - physiopathology</topic><topic>Idiopathic Pulmonary Fibrosis - therapy</topic><topic>obstructive sleep apnoea</topic><topic>Prevalence</topic><topic>pulmonary hypertension</topic><topic>Sleep Apnea, Obstructive - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Boer, Kaïssa</creatorcontrib><creatorcontrib>Lee, Joyce S.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Respirology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Boer, Kaïssa</au><au>Lee, Joyce S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review</atitle><jtitle>Respirology (Carlton, Vic.)</jtitle><addtitle>Respirology</addtitle><date>2016-08</date><risdate>2016</risdate><volume>21</volume><issue>6</issue><spage>995</spage><epage>1004</epage><pages>995-1004</pages><issn>1323-7799</issn><eissn>1440-1843</eissn><abstract>Co‐morbidities in idiopathic pulmonary fibrosis are common. These co‐morbidities include obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression. The presence of co‐morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality of life, morbidity and mortality. Despite the high prevalence of certain co‐morbidities in idiopathic pulmonary fibrosis, the optimal screening and management of many of these conditions remains unclear. The impact of co‐morbidities on this patient population is becoming more apparent. Their relevance will only increase as significant effort is being made to develop novel therapeutics that will alter the disease trajectory of patients with idiopathic pulmonary fibrosis. The purpose of this review is to focus on the epidemiology, pathophysiology, diagnosis and management of select co‐morbidities, including obstructive sleep apnoea, gastro‐oesophageal reflux disease, pulmonary hypertension and depression, in idiopathic pulmonary fibrosis.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>26365251</pmid><doi>10.1111/resp.12622</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1323-7799
ispartof Respirology (Carlton, Vic.), 2016-08, Vol.21 (6), p.995-1004
issn 1323-7799
1440-1843
language eng
recordid cdi_proquest_miscellaneous_1808640606
source MEDLINE; Wiley Journals
subjects Comorbidity
depression
Depression - epidemiology
Disease Management
gastro-oesophageal reflux disease
Gastroesophageal Reflux - epidemiology
Humans
Hypertension, Pulmonary - epidemiology
idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis - diagnosis
Idiopathic Pulmonary Fibrosis - epidemiology
Idiopathic Pulmonary Fibrosis - physiopathology
Idiopathic Pulmonary Fibrosis - therapy
obstructive sleep apnoea
Prevalence
pulmonary hypertension
Sleep Apnea, Obstructive - epidemiology
title Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A10%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Under-recognised%20co-morbidities%20in%20idiopathic%20pulmonary%20fibrosis:%20A%20review&rft.jtitle=Respirology%20(Carlton,%20Vic.)&rft.au=de%20Boer,%20Ka%C3%AFssa&rft.date=2016-08&rft.volume=21&rft.issue=6&rft.spage=995&rft.epage=1004&rft.pages=995-1004&rft.issn=1323-7799&rft.eissn=1440-1843&rft_id=info:doi/10.1111/resp.12622&rft_dat=%3Cproquest_cross%3E1804865593%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1804865593&rft_id=info:pmid/26365251&rfr_iscdi=true